CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs

Neutral
AI Analysis

Summary

Ying Huang, former CEO of Legend, is now leading K2 Therapeutics, a biotech startup focused on licensing drug candidates from China-based biotechs.

Importance:2/10
Sentiment:
0.00
managementleadership changedrug licensingChina biotech
Related Companies

Read the original article

Published by BioPharma Dive on August 11, 2026 4:12 PM

Read Original